September 24, 2024 11:45 ET | Source: Transgene S.A. Transgene S.A.
2024 Half Year Financial Report
Attachment
Transgene and NEC Report 100% Three-Year Disease-Free Survival with TG4050 and Publish Phase 1 Results in Nature Communications
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2026
